Consortium for Stem Cell Therapies
New Center Creates Stem Cells and Hope for Cures
When state voters in 2008 approved a constitutional amendment allowing embryonic stem cell research, University of Michigan scientists promised to put this new freedom to work finding new treatments and cures for disease.
And in early 2009 the A. Alfred Taubman Medical Research Institute took an important step to honor that pledge – forming the Consortium for Stem Cell Therapies.
This state-of-the-art facility, located at the U-M Medical School, already has become a national leader in the derivation and distribution of stem cell lines.
“Embryonic stem cell research is the most important advancement in medical science since the advent of antibiotics a half century ago,” said A. Alfred Taubman, Founder and Chair of the Taubman Institute. “The creation of this Consortium positions the state of Michigan at the forefront of this promising scientific and medical frontier.”
The Consortium was among the first centers in the country to derive stem cell lines linked to a database containing genetic and medical-history information about the embryo donors and their families. This database will enable researchers to pinpoint stem cells that carry the genes for specific diseases. It has produced four such lines and has plans for many others.
“Scientists throughout the University of Michigan and the state of Michigan will benefit from this new stem cell center,” said. Eva Feldman, M.D., Ph.D., director of the Taubman Institute.
“We will now be able to obtain stem cell lines, specifically targeted to understand the causes of specific diseases and to develop new therapies. Can you imagine what a powerful tool these stem cell lines will be?”
The co-directors of the stem cell center, Dr. Sue O’Shea and Dr, Gary Smith, have been appointed Taubman Institute Scientists for their roles at the Consortium.
For information about the Consortium and how to inquire about donating embryos please click here.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.